Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
Yujing SheWei Chen

Abstract

To evaluate effects of a novel multi-ingredient artificial tear formulation containing carboxymethylcellulose (CMC) and hyaluronic acid (HA) in a murine dry eye model. Dry eye was induced in mice (C57BL/6) using an intelligently controlled environmental system (ICES). CMC+HA (Optive Fusion™), CMC-only (Refresh Tears(®)), and HA-only (Hycosan(®)) artificial tears and control phosphate-buffered saline (PBS) were administered 4 times daily and compared with no treatment (n = 64 eyes per group). During regimen 1 (prevention regimen), mice were administered artificial tears or PBS for 14 days (starting day 0) while they were exposed to ICES, and assessed on days 0 and 14. During regimen 2 (treatment regimen), mice exposed to ICES for 14 days with no intervention were administered artificial tears or PBS for 14 days (starting day 14) while continuing exposure to ICES, and assessed on days 0, 14, and 28. Corneal fluorescein staining and conjunctival goblet cell density were measured. Artificial tear-treated mice had significantly better outcomes than control groups on corneal staining and goblet cell density (P < 0.01). Mice administered CMC+HA also showed significantly lower corneal fluorescein staining and higher goblet cell density...Continue Reading

Associated Clinical Trials

References

Jan 30, 2002·The British Journal of Ophthalmology·Pasquale AragonaGiovanni Milazzo
Sep 26, 2003·Investigative Ophthalmology & Visual Science·Xiu Jun SongStephen C Pflugfelder
May 19, 2004·The British Journal of Ophthalmology·J A P GomesH S Dua
Jul 27, 2005·Investigative Ophthalmology & Visual Science·Stefano BarabinoM Reza Dana
Nov 15, 2006·Cornea·Ashley BehrensUNKNOWN Dysfunctional tear syndrome study group
Mar 29, 2007·Investigative Ophthalmology & Visual Science·Qian GarrettMark Willcox
Apr 7, 2007·Cornea·Peter A Simmons, Joseph G Vehige
Apr 10, 2007·Journal français d'ophtalmologie·C Baudouin
Apr 4, 2008·Investigative Ophthalmology & Visual Science·Wei ChenJia Qu
May 6, 2008·Developments in Ophthalmology·Stefan SchraderGerd Geerling
Jul 5, 2008·Current Eye Research·Qian GarrettMark D P Willcox
Aug 5, 2008·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Jerry R PaughDavid L Meadows
Aug 19, 2009·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Michael J Doughty, Sara Glavin
Mar 30, 2010·American Journal of Ophthalmology·Roger VogelUNKNOWN Sodium Hyaluronate Ophthalmic Solution Study Group
Jan 31, 2012·European Journal of Ophthalmology·Christophe BaudouinCatherine Creuzot-Garcher
Aug 24, 2013·Investigative Ophthalmology & Visual Science·Wei ChenQian Garrett
May 20, 2014·Experimental Eye Research·Qinxiang ZhengWei Chen

❮ Previous
Next ❯

Citations

Mar 11, 2017·International Ophthalmology Clinics·Koray Gumus, Stephen C Pflugfelder
Aug 3, 2019·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Chiara PosarelliMichele Figus
Jun 9, 2020·Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association·Katsuhide YamasakiLyndon Jones
Mar 7, 2021·Carbohydrate Polymers·Gloria Huerta Ángeles, Kristina Nešporová

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.